The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor - PubMed (original) (raw)
Review
. 1993 Aug 13:Doc No 83:[2305 words; 32 paragraphs].
Affiliations
- PMID: 8306013
Review
The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor
G G Mitchell et al. Online J Curr Clin Trials. 1993.
Abstract
Objectives: To compare oxytocin plus ergometrine against oxytocin alone, when administered as part of the active management of the 3rd stage of labor, in terms of postpartum hemorrhage and manual removal of the placenta.
Design: A double-blind, randomized controlled trial.
Setting: A university teaching hospital: Hope Hospital, Salford.
Patients: All women delivering in the hospital over the period of the trial, except those for whom a cesarean section was planned, or who had significant hypertension or cardiac disease.
Interventions: Syntometrine (5 units of oxytocin with 0.5 mg of ergometrine) versus 5 units of Syntocinon (oxytocin), both given by intramuscular injection with delivery of the anterior shoulder.
Main outcome measures: Postpartum blood loss, the length of the 3rd stage of labor, and the need for manual removal of the placenta.
Results: Four hundred sixty-one women were recruited, 230 allocated to ergometrine plus oxytocin and 231 to oxytocin alone. The duration of the 3rd stage of labor in each group was similar (difference in means 0.2 mins; 95% confidence interval [CI], -1.0 to 1.5) and the need for manual removal of the placenta (odds ratio [OR] 1.21; 95% CI, 0.37 to 4.00). There was less postpartum blood loss in the oxytocin plus ergometrine group, reflected in the lower incidence of primary postpartum hemorrhage (> 500 mL) (OR 0.37; 95% CI, 0.16 to 0.85).
Conclusions: Judged on the basis of this trial alone, oxytocin plus ergometrine is more effective than oxytocin alone in the prevention of postpartum hemorrhage. However, evidence from other trials shows that the ergometrine component not uncommonly has side effects of nausea, vomiting, and raised blood pressure. The implications for practice therefore depend on the relative weights placed on these competing risks by women and clinicians. Further research is needed to quantify these along with research into possible differential effects on longer-term outcomes and into the implications of a higher dose of oxytocin.
Similar articles
- Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A. Gallos ID, et al. Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2. Cochrane Database Syst Rev. 2018. PMID: 29693726 Free PMC article. Updated. Review. - Prevention of postpartum hemorrhage, safety and efficacy.
Abu-Omar AA. Abu-Omar AA. Saudi Med J. 2001 Dec;22(12):1118-21. Saudi Med J. 2001. PMID: 11802188 Retracted. - Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage.
Saito K, Haruki A, Ishikawa H, Takahashi T, Nagase H, Koyama M, Endo M, Hirahara F. Saito K, et al. J Obstet Gynaecol Res. 2007 Jun;33(3):254-8. doi: 10.1111/j.1447-0756.2007.00520.x. J Obstet Gynaecol Res. 2007. PMID: 17578351 Clinical Trial. - Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor.
Bamigboye AA, Merrell DA, Hofmeyr GJ, Mitchell R. Bamigboye AA, et al. Acta Obstet Gynecol Scand. 1998 Feb;77(2):178-81. Acta Obstet Gynecol Scand. 1998. PMID: 9512323 Clinical Trial. - Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
Westhoff G, Cotter AM, Tolosa JE. Westhoff G, et al. Cochrane Database Syst Rev. 2013 Oct 30;(10):CD001808. doi: 10.1002/14651858.CD001808.pub2. Cochrane Database Syst Rev. 2013. PMID: 24173606 Updated. Review.
Cited by
- Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.
McDonald S, Abbott JM, Higgins SP. McDonald S, et al. Cochrane Database Syst Rev. 2004;2004(1):CD000201. doi: 10.1002/14651858.CD000201.pub2. Cochrane Database Syst Rev. 2004. PMID: 14973949 Free PMC article. Review. - Prophylactic use of ergot alkaloids in the third stage of labour.
Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Liabsuetrakul T, et al. Cochrane Database Syst Rev. 2018 Jun 7;6(6):CD005456. doi: 10.1002/14651858.CD005456.pub3. Cochrane Database Syst Rev. 2018. PMID: 29879293 Free PMC article. Review. - Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A. Gallos ID, et al. Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2. Cochrane Database Syst Rev. 2018. PMID: 29693726 Free PMC article. Updated. Review. - Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, Williams MJ, Diaz V, Pasquale J, Chamillard M, Widmer M, Tunçalp Ö, Hofmeyr GJ, Althabe F, Gülmezoglu AM, Vogel JP, Oladapo OT, Coomarasamy A. Gallos ID, et al. Cochrane Database Syst Rev. 2018 Dec 19;12(12):CD011689. doi: 10.1002/14651858.CD011689.pub3. Cochrane Database Syst Rev. 2018. PMID: 30569545 Free PMC article. - What measured blood loss tells us about postpartum bleeding: a systematic review.
Sloan NL, Durocher J, Aldrich T, Blum J, Winikoff B. Sloan NL, et al. BJOG. 2010 Jun;117(7):788-800. doi: 10.1111/j.1471-0528.2010.02567.x. Epub 2010 Apr 20. BJOG. 2010. PMID: 20406227 Free PMC article. Review.